Condensed Consolidated Shareholders' Equity (Unaudited) - USD ($)	Common Stock	Preferred Stock	Additional Paid-In Capital	Accumulated Deficit	Unearned Shareholders' Compensation	Total
Beginning Balance, Shares at Aug. 31, 2019	4,822,016
Beginning Balance, Amount at Aug. 31, 2019	$ 4,822		$ 6,520,980	$ (1,452,020)	$ (842,657)	$ 4,231,125
Common shares issued for cash at $0.0140 per share, Shares
Common shares issued for cash at $0.0140 per share, Amount
Common shares issued from note conversions, shares
Common shares issued from note conversions, amount
Common shares issued from warrant exercises, shares
Common shares issued from warrant exercises, amount
Common shares issued to officers for services, shares
Common shares issued to officers for services, amount					85,102
Common shares returned due to officer resignations, shares
Common shares returned due to officer resignations, amount
Put shares issued for cash. shares
Put shares issued for cash, amount
Common shares issued for consulting services, shares
Common shares issued for consulting services, amount
Series A preferred shares issued, shares
Series A preferred shares issued, amount
Series B preferred shares issued, shares
Series B preferred shares issued, amount
Series C preferred shares issued, shares
Series C preferred shares issued, amount
Warrant shares issued in conjuction with convertible notes			133,023			133,023
Warrant termination and exercised
Net Loss				(415,331)		(415,331)
Ending Balance, Shares at Feb. 29, 2020	4,822,016
Ending Balance, Amount at Feb. 29, 2020	$ 4,822		6,654,003	(1,867,351)	(757,556)	4,033,918
Beginning Balance, Shares at Aug. 31, 2020	46,661,417
Beginning Balance, Amount at Aug. 31, 2020	$ 46,661		7,271,983	(2,970,881)	(391,667)	$ 3,956,097
Common shares issued for cash at $0.0140 per share, Shares	19,000,000					19,000,000
Common shares issued for cash at $0.0140 per share, Amount	$ 19,000		247,000			$ 266,000
Common shares issued from note conversions, shares	25,406,238					25,406,238
Common shares issued from note conversions, amount	$ 25,406		158,347			$ 183,753
Common shares issued from warrant exercises, shares	56,407,922					56,407,922
Common shares issued from warrant exercises, amount	$ 56,408		81,358			$ 137,766
Common shares issued to officers for services, shares	1,500,000
Common shares issued to officers for services, amount	$ 1,500		43,500		(14,973)	$ 30,027
Common shares returned due to officer resignations, shares	(261,111)					261,111
Common shares returned due to officer resignations, amount	$ (261)		(391,405)		560,833	$ 169,167
Put shares issued for cash. shares	15,220,000					15,220,000
Put shares issued for cash, amount	$ 15,220		721,908			$ 737,128
Common shares issued for consulting services, shares	9,500,000					9,500,000
Common shares issued for consulting services, amount	$ 9,500		275,500			$ 285,000
Series A preferred shares issued, shares		100,000
Series A preferred shares issued, amount		$ 100				100
Series B preferred shares issued, shares		20,000
Series B preferred shares issued, amount		$ 20	319,980			320,000
Series C preferred shares issued, shares		280,025
Series C preferred shares issued, amount		$ 280	243,220			243,500
Warrant shares issued in conjuction with convertible notes
Warrant termination and exercised			(145,423)			(145,423)
Adjustment to retained earning				55,347		55,347
Net Loss				(879,301)		(879,301)
Ending Balance, Shares at Feb. 28, 2021	173,434,466	400,025
Ending Balance, Amount at Feb. 28, 2021	$ 173,434	$ 400	$ 8,825,968	$ (3,794,835)	$ (14,973)	$ 5,189,995